Avantor (NYSE:AVTR) Price Target Raised to $14.00

Avantor (NYSE:AVTR) had its price objective raised by Morgan Stanley from $10.00 to $14.00 in a research report released on Thursday morning, MarketBeat Ratings reports. The brokerage currently has an equal weight rating on the stock.

Several other analysts also recently commented on AVTR. Barclays upped their price objective on shares of Avantor from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, June 24th. Jefferies Financial Group upgraded shares of Avantor from an “underperform” rating to a “hold” rating and set a $13.00 target price for the company in a research report on Wednesday. TD Cowen reaffirmed a “hold” rating on shares of Avantor in a report on Wednesday, July 15th. Zacks Research raised Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, April 30th. Finally, Wall Street Zen raised Avantor from a “hold” rating to a “buy” rating in a research report on Saturday, June 27th. Two research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Avantor presently has an average rating of “Hold” and a consensus target price of $12.00.

Avantor Trading Down 0.6%

Avantor stock opened at $13.78 on Thursday. The company has a quick ratio of 1.17, a current ratio of 1.78 and a debt-to-equity ratio of 0.65. Avantor has a 52 week low of $7.26 and a 52 week high of $15.93. The company has a market capitalization of $9.32 billion, a price-to-earnings ratio of -16.41, a price-to-earnings-growth ratio of 13.95 and a beta of 0.94. The stock has a 50-day moving average price of $10.26 and a 200 day moving average price of $9.45.

Avantor (NYSE:AVTR) last issued its earnings results on Wednesday, July 29th. The company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.61 billion. During the same quarter in the prior year, the firm earned $0.24 earnings per share. Avantor’s revenue for the quarter was up .5% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Sell-side analysts anticipate that Avantor will post 0.81 EPS for the current year.

Insider Activity at Avantor

In other news, Director Gregory T. Lucier bought 10,000 shares of the business’s stock in a transaction dated Friday, May 8th. The stock was purchased at an average cost of $8.32 per share, with a total value of $83,200.00. Following the acquisition, the director directly owned 60,000 shares in the company, valued at $499,200. This trade represents a 20.00% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.28% of the stock is owned by insiders.

Institutional Trading of Avantor

Several hedge funds and other institutional investors have recently added to or reduced their stakes in AVTR. Private Management Group Inc. raised its position in shares of Avantor by 50.4% in the fourth quarter. Private Management Group Inc. now owns 2,456,859 shares of the company’s stock worth $28,156,000 after acquiring an additional 823,572 shares during the period. Brickwood Asset Management LLP grew its position in shares of Avantor by 6,891.9% during the 4th quarter. Brickwood Asset Management LLP now owns 3,184,043 shares of the company’s stock valued at $36,489,000 after acquiring an additional 3,138,504 shares during the period. SG Americas Securities LLC grew its position in shares of Avantor by 209.5% during the 4th quarter. SG Americas Securities LLC now owns 401,969 shares of the company’s stock valued at $4,607,000 after acquiring an additional 272,093 shares during the period. Agman Capital LLC purchased a new position in shares of Avantor in the 4th quarter valued at about $3,915,000. Finally, Thornburg Investment Management Inc. increased its stake in shares of Avantor by 29.4% in the 4th quarter. Thornburg Investment Management Inc. now owns 576,959 shares of the company’s stock valued at $6,612,000 after purchasing an additional 131,186 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Key Avantor News

Here are the key news stories impacting Avantor this week:

• Positive Sentiment: Avantor reported second-quarter adjusted EPS of $0.21, exceeding the $0.19 consensus estimate, while revenue of $1.69 billion also topped expectations. The return of organic growth at its VWR business helped support the improved results and outlook. Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised
• Positive Sentiment: Management issued 2026 adjusted EPS guidance of $0.80 to $0.83 and is targeting adjusted net leverage below 3x, signaling confidence in earnings growth and balance-sheet improvement. Avantor outlines 2026 adjusted EPS and leverage targets
• Positive Sentiment: Analysts raised their price targets following the earnings report: Wells Fargo moved to $16 and maintained an overweight rating, Stifel raised its target to $15 with a hold rating, and Morgan Stanley increased its target to $14 with an equal-weight rating.
• Positive Sentiment: From a technical perspective, AVTR’s 50-day moving average has crossed above its 200-day moving average, forming a “golden cross.” This typically signals improving momentum and may attract technical traders. Avantor flashes golden cross signal
• Neutral Sentiment: Wolfe Research upgraded Avantor from “strong sell” to “hold,” reducing a major negative stance but stopping short of endorsing the shares as a buy.
• Negative Sentiment: Despite the earnings beat, revenue grew only 0.5% year over year, prior-year EPS was higher at $0.24, and the company continues to report a negative net margin. Several analyst ratings remain neutral, suggesting that much of the near-term recovery may already be reflected in the stock.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.